Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
CLX Stock Forecast 2026-2027
$92.16
Current Price
$11.14B
Market Cap
Buy 2
Hold 13
Sell 4
Wall St Analyst Ratings
Distance to CLX Price Targets
+76.9%
To High Target of $163.00
+8.5%
To Median Target of $100.00
-9.9%
To Low Target of $83.00
CLX Price Momentum
+5.8%
1 Week Change
-14.4%
1 Month Change
-31.6%
1 Year Change
-8.6%
Year-to-Date Change
-33.7%
From 52W High of $138.94
+8.8%
From 52W Low of $84.70
📊 TOP ANALYST CALLS
Did CLX Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Clorox is one of their latest high-conviction picks.
Latest CLX Stock Price Targets & Analyst Predictions
Based on our analysis of 27 Wall Street analysts, CLX has a neutral consensus with a median price target of $100.00 (ranging from $83.00 to $163.00). The overall analyst rating is Hold (5.8/10). Currently trading at $92.16, the median forecast implies a 8.5% upside. This outlook is supported by 2 Buy, 13 Hold, and 4 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
CLX Analyst Ratings
2
Buy
13
Hold
4
Sell
CLX Price Target Range
Low
$83.00
Average
$100.00
High
$163.00
Current: $92.16
Latest CLX Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for CLX.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| May 4, 2026 | Barclays | Lauren Lieberman | Underweight | Maintains | $85.00 |
| May 1, 2026 | JP Morgan | Andrea Teixeira | Underweight | Maintains | $95.00 |
| May 1, 2026 | Evercore ISI Group | Javier Escalante | Underperform | Maintains | $110.00 |
| May 1, 2026 | Wells Fargo | Chris Carey | Equal-Weight | Maintains | $100.00 |
| May 1, 2026 | UBS | Peter Grom | Neutral | Maintains | $96.00 |
| May 1, 2026 | Citigroup | Filippo Falorni | Neutral | Maintains | $97.00 |
| Apr 23, 2026 | Morgan Stanley | Dara Mohsenian | Equal-Weight | Maintains | $110.00 |
| Apr 21, 2026 | Jefferies | Kaumil Gajrawala | Buy | Maintains | $139.00 |
| Apr 17, 2026 | JP Morgan | Andrea Teixeira | Underweight | Downgrade | $99.00 |
| Apr 15, 2026 | Barclays | Lauren Lieberman | Underweight | Maintains | $102.00 |
| Apr 15, 2026 | Citigroup | Filippo Falorni | Neutral | Maintains | $110.00 |
| Apr 14, 2026 | Barclays | Lauren Lieberman | Underweight | Maintains | $102.00 |
| Apr 8, 2026 | Wells Fargo | Chris Carey | Equal-Weight | Maintains | $110.00 |
| Apr 7, 2026 | UBS | Peter Grom | Neutral | Maintains | $110.00 |
| Mar 30, 2026 | Deutsche Bank | Stephen Powers | Hold | Maintains | $101.00 |
| Feb 5, 2026 | Morgan Stanley | Dara Mohsenian | Equal-Weight | Maintains | $136.00 |
| Feb 4, 2026 | JP Morgan | Andrea Teixeira | Neutral | Maintains | $117.00 |
| Feb 4, 2026 | Citigroup | Filippo Falorni | Neutral | Maintains | $115.00 |
| Feb 4, 2026 | UBS | Peter Grom | Neutral | Maintains | $121.00 |
| Feb 4, 2026 | Evercore ISI Group | Javier Escalante | Underperform | Maintains | $115.00 |
Clorox Co-The (CLX) Competitors
The following stocks are similar to Clorox based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Clorox Co-The (CLX) Financial Data
Clorox Co-The has a market capitalization of $11.14B with a P/E ratio of 15.0x. The company generates $6.76B in trailing twelve-month revenue with a 11.2% profit margin.
Revenue growth is +0.1% quarter-over-quarter, while maintaining an operating margin of +17.0% and return on equity of +546.1%.
Valuation Metrics
Market Cap
$11.14B
Enterprise Value
$14.60B
P/E Ratio
15.0x
PEG Ratio
7.5x
Price/Sales
1.6x
Growth & Margins
Revenue Growth (YoY)
+0.1%
Gross Margin
+43.2%
Operating Margin
+17.0%
Net Margin
+11.2%
EPS Growth
+0.5%
Financial Health
Cash/Price Ratio
+10.7%
Current Ratio
0.8x
Debt/Equity
4,876.1x
ROE
+546.1%
ROA
+11.0%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Clorox Co-The (CLX) Business Model
About Clorox Co-The
What They Do
Manufactures consumer and professional cleaning products.
Business Model
The company operates through four segments: Health and Wellness, Household, Lifestyle, and International. It generates revenue by selling a wide array of cleaning and disinfecting solutions, along with other consumer products, both in retail and institutional markets. Key brands include Clorox, Glad, and Brita, which cater to various consumer needs.
Additional Information
Founded in 1913 and headquartered in Oakland, California, the company is a significant player in the consumer defensive sector, focusing on innovation in health, hygiene, and convenience. Its diverse portfolio and established brands provide a competitive advantage in maintaining market presence.
Company Information
Sector
Consumer Defensive
Industry
Household & Personal Products
Employees
7,600
CEO
Ms. Linda J. Rendle
Country
United States
IPO Year
1983
Website
www.thecloroxcompany.comClorox Co-The (CLX) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
CLX Q3 Earnings Beat Estimates on Lower Spending, Cost Savings
Clorox tops Q3 EPS estimates on cost cuts despite flat sales. It trims the FY26 outlook after GOJO close and bigger margin pressure.
May 01, 2026
By Zacks Equity Research
Analyst Blog
Compared to Estimates, Clorox (CLX) Q3 Earnings: A Look at Key Metrics
The headline numbers for Clorox (CLX) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Apr 30, 2026
By Zacks Equity Research
Fundamental Analysis
Clorox (CLX) Beats Q3 Earnings and Revenue Estimates
Clorox (CLX) delivered earnings and revenue surprises of +10.83% and +1.36%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Apr 30, 2026
By Zacks Equity Research
Tale of the Tape
Latest News
Quick Summary
Clorox (CLX) is rated a 'Buy' at $87.1, with a 37% undervaluation and 44.7% potential return. Short-term challenges may ease, while long-term growth is supported by acquisitions and expansion.
Why It Matters
Clorox's strong buy rating and significant undervaluation signal potential for high returns. Easing headwinds and strategic growth initiatives may enhance long-term profitability, despite dividend payout concerns.
Source: Seeking Alpha
Market Sentiment:
Positive
Quick Summary
Johnson Fistel, PLLP is investigating potential claims for investors of The Clorox Company (NYSE: CLX) regarding possible recoveries of losses under federal securities laws.
Why It Matters
Investigations into Clorox's executives may signal potential legal troubles, impacting stock performance and investor confidence, which could lead to volatility in share prices.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Clorox Corporation (NYSE: CLX) reported positive third-quarter results and revised its full-year guidance upward.
Why It Matters
Clorox's strong Q3 results and revised guidance suggest improved financial health, potentially boosting investor confidence and impacting stock performance positively.
Source: Benzinga
Market Sentiment:
Negative
Quick Summary
Clorox lowered its annual profit forecast due to reduced demand for cleaning products, citing increased costs from geopolitical tensions related to the U.S.-Israeli war on Iran.
Why It Matters
Clorox's profit forecast cut signals declining demand and rising costs, potentially impacting revenue and stock performance, leading to investor caution.
Source: Reuters
Market Sentiment:
Negative
Quick Summary
The cleaning-products maker revised its earnings per share outlook for the year to $4.78-$4.98, down from the previous range of $5.60-$5.95.
Why It Matters
Lowered earnings guidance signals potential revenue issues, affecting profitability and investor confidence, likely leading to stock price declines.
Source: WSJ
Market Sentiment:
Negative
Quick Summary
Clorox Company (CLX) held its Q3 2026 earnings call, discussing financial performance and future outlook. Further details can be found in the full transcript.
Why It Matters
Clorox's Q3 earnings reveal financial performance and growth trends, impacting stock valuation and investor sentiment, influencing investment decisions in consumer goods.
Source: Seeking Alpha
Market Sentiment:
Neutral
Frequently Asked Questions About CLX Stock
What is Clorox Co-The's (CLX) stock forecast for 2026?
Based on our analysis of 27 Wall Street analysts, Clorox Co-The (CLX) has a median price target of $100.00. The highest price target is $163.00 and the lowest is $83.00.
Is CLX stock a good investment in 2026?
According to current analyst ratings, CLX has 2 Buy ratings, 13 Hold ratings, and 4 Sell ratings. The stock is currently trading at $92.16. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for CLX stock?
Wall Street analysts predict CLX stock could reach $100.00 in the next 12 months. This represents a 8.5% increase from the current price of $92.16. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Clorox Co-The's business model?
The company operates through four segments: Health and Wellness, Household, Lifestyle, and International. It generates revenue by selling a wide array of cleaning and disinfecting solutions, along with other consumer products, both in retail and institutional markets. Key brands include Clorox, Glad, and Brita, which cater to various consumer needs.
What is the highest forecasted price for CLX Clorox Co-The?
Price targets from Wall Street analysts for CLX are not currently available. The stock is trading at $92.16.
What is the lowest forecasted price for CLX Clorox Co-The?
Price targets from Wall Street analysts for CLX are not currently available. The stock is trading at $92.16.
What is the overall CLX consensus from analysts for Clorox Co-The?
The overall analyst consensus for CLX is neutral. Out of 27 Wall Street analysts, 2 rate it as Buy, 13 as Hold, and 4 as Sell, with a median price target of $100.00.
How accurate are CLX stock price projections?
Stock price projections, including those for Clorox Co-The, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: May 9, 2026 7:16 PM UTC